Among the GLP1-RA agents, once-weekly semaglutide may be especially promising in type 1 diabetes, as this agent has demonstrated superiority over other GLP1-RAs in terms of glycaemic control and weight loss in type 2 diabetes, as well as good tolerability [56]
Food And Groceries In its survey of 300 patients and report titled Could obesity drugs take a bite out of the food industry?, Morgan Stanley found that GLP-1s lead to a reduction in calorie intake per patient of between 20% and 30%
Clinically evident deficiency
Additionally, when HEK293 cells are cotransfected with MC3R and a GHSR1a mutant showing impaired or absent constitutive activity, heterodimerization still occurs but amplification of -MSH-induced cAMP accumulation is lost, suggesting that the twofold increase in cAMP accumulation depends on GHSR1a basal activity (Rediger et al., 2011)
So pretty robust data there